Pharmaceuticals

Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US$ 3.46 Billion in 2023 and is expected to reach to US$ 5.26 Billion by 2031; it is estimated to record a CAGR of 5.4% from 2023 to 2031

• Pharmaceuticals

Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US$ 3.46 Billion in 2023 and is expected to reach to US$ 5.26 Billion by 2031; it is estimated to record a CAGR of 5.4% from 2023 to 2031

Market News Insights December 2, 2024

The polycystic ovarian syndrome (PCOS) treatment market in Asia Pacific is expected to register the highest CAGR...

Read More Read more about Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US$ 3.46 Billion in 2023 and is expected to reach to US$ 5.26 Billion by 2031; it is estimated to record a CAGR of 5.4% from 2023 to 2031

Eye Allergy Treatment Market was valued at US$ 3.59 Billion in 2022 and is expected to reach to US$ 5.69 Billion by 2030; it is estimated to record a CAGR of 5.9% from 2022 to 2030

• Pharmaceuticals

Eye Allergy Treatment Market was valued at US$ 3.59 Billion in 2022 and is expected to reach to US$ 5.69 Billion by 2030; it is estimated to record a CAGR of 5.9% from 2022 to 2030

Market News Insights November 26, 2024

Eye allergy treatment includes products and solutions that are used to treat and manage allergies affecting the...

Read More Read more about Eye Allergy Treatment Market was valued at US$ 3.59 Billion in 2022 and is expected to reach to US$ 5.69 Billion by 2030; it is estimated to record a CAGR of 5.9% from 2022 to 2030

Mesotherapy Market was valued at US$ 561.20 Million in 2022 and is expected to reach to US$ 1,148.60 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

• Pharmaceuticals

Mesotherapy Market was valued at US$ 561.20 Million in 2022 and is expected to reach to US$ 1,148.60 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

Market News Insights November 21, 2024

Factors such as simplified and minimally invasive procedures, and wide range of applications; and improvements in comfort,...

Read More Read more about Mesotherapy Market was valued at US$ 561.20 Million in 2022 and is expected to reach to US$ 1,148.60 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

Ovarian Cancer Drugs Market was valued at US$ 2.1 Billion in 2022 and is expected to reach to US$ 3.8 Billion by 2030; it is estimated to record a CAGR of 7.7% from 2022 to 2030

• Pharmaceuticals

Ovarian Cancer Drugs Market was valued at US$ 2.1 Billion in 2022 and is expected to reach to US$ 3.8 Billion by 2030; it is estimated to record a CAGR of 7.7% from 2022 to 2030

Market News Insights November 20, 2024

Rising Incidence of Ovarian Cancer Propels Demand for Therapeutic Options Ovarian cancer is the seventh most common...

Read More Read more about Ovarian Cancer Drugs Market was valued at US$ 2.1 Billion in 2022 and is expected to reach to US$ 3.8 Billion by 2030; it is estimated to record a CAGR of 7.7% from 2022 to 2030

Opioids Market was valued at US$ 12.93 Billion in 2023 and is expected to reach to US$ 15.03 Billion by 2031; it is estimated to record a CAGR of 1.9% from 2023 to 2031

• Pharmaceuticals

Opioids Market was valued at US$ 12.93 Billion in 2023 and is expected to reach to US$ 15.03 Billion by 2031; it is estimated to record a CAGR of 1.9% from 2023 to 2031

Market News Insights November 19, 2024

Surging Chronic Pain Incidence Drives Opioids Market Growth Chronic diseases such as cardiovascular disease, cancer, musculoskeletal diseases,...

Read More Read more about Opioids Market was valued at US$ 12.93 Billion in 2023 and is expected to reach to US$ 15.03 Billion by 2031; it is estimated to record a CAGR of 1.9% from 2023 to 2031

Hormone Replacement Therapy Market was valued at US$ 8.46 Billion in 2023 and is expected to reach to US$ 14.82 Billion by 2031; it is estimated to record a CAGR of 7.3% from 2023 to 2031

• Pharmaceuticals

Hormone Replacement Therapy Market was valued at US$ 8.46 Billion in 2023 and is expected to reach to US$ 14.82 Billion by 2031; it is estimated to record a CAGR of 7.3% from 2023 to 2031

Market News Insights November 19, 2024

The hormone replacement therapy market in Asia Pacific is expected to register the highest CAGR during the...

Read More Read more about Hormone Replacement Therapy Market was valued at US$ 8.46 Billion in 2023 and is expected to reach to US$ 14.82 Billion by 2031; it is estimated to record a CAGR of 7.3% from 2023 to 2031

Non-Gelatin Empty Capsules Market was valued at US$ 2.33 Billion in 2022 and is expected to reach to US$ 4.64 Billion by 2030; it is estimated to record a CAGR of 9.0% from 2022 to 2030

• Pharmaceuticals

Non-Gelatin Empty Capsules Market was valued at US$ 2.33 Billion in 2022 and is expected to reach to US$ 4.64 Billion by 2030; it is estimated to record a CAGR of 9.0% from 2022 to 2030

Market News Insights November 18, 2024

Non-gelatin empty capsules are widely used in the pharmaceutical and nutraceutical industries as an alternative to gelatin...

Read More Read more about Non-Gelatin Empty Capsules Market was valued at US$ 2.33 Billion in 2022 and is expected to reach to US$ 4.64 Billion by 2030; it is estimated to record a CAGR of 9.0% from 2022 to 2030

Hypopigmentation Disorder Treatment Market was valued at US$ 4.4 Billion in 2023 and is expected to reach to US$ 6.7 Billion by 2031; it is estimated to record a CAGR of 5.41% from 2023 to 2031

• Pharmaceuticals

Hypopigmentation Disorder Treatment Market was valued at US$ 4.4 Billion in 2023 and is expected to reach to US$ 6.7 Billion by 2031; it is estimated to record a CAGR of 5.41% from 2023 to 2031

Market News Insights November 15, 2024

Hypopigmentation disorders include vitiligo and albinism, among others. The rising prevalence of hypopigmentation disorders, increased awareness related...

Read More Read more about Hypopigmentation Disorder Treatment Market was valued at US$ 4.4 Billion in 2023 and is expected to reach to US$ 6.7 Billion by 2031; it is estimated to record a CAGR of 5.41% from 2023 to 2031

Prostate Cancer Treatment Market was valued at US$ 19.07 Billion in 2022 and is expected to reach to US$ 34.11 Billion by 2030; it is estimated to record a CAGR of 7.5% from 2022 to 2030

• Pharmaceuticals

Prostate Cancer Treatment Market was valued at US$ 19.07 Billion in 2022 and is expected to reach to US$ 34.11 Billion by 2030; it is estimated to record a CAGR of 7.5% from 2022 to 2030

Market News Insights November 14, 2024

The increasing prevalence of prostate cancer and surging strategic initiatives by companies propel the Prostate Cancer Treatment...

Read More Read more about Prostate Cancer Treatment Market was valued at US$ 19.07 Billion in 2022 and is expected to reach to US$ 34.11 Billion by 2030; it is estimated to record a CAGR of 7.5% from 2022 to 2030

Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 Billion in 2023 and is expected to reach to US$ 31.67 Billion by 2031; it is estimated to record a CAGR of 3.50% from 2023 to 2031

• Pharmaceuticals

Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 Billion in 2023 and is expected to reach to US$ 31.67 Billion by 2031; it is estimated to record a CAGR of 3.50% from 2023 to 2031

Market News Insights November 14, 2024

Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative...

Read More Read more about Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 Billion in 2023 and is expected to reach to US$ 31.67 Billion by 2031; it is estimated to record a CAGR of 3.50% from 2023 to 2031